| Ytd | -8.44% | |
| 1y | -6.59% |
| Open | 65.93 | Prev Close | 65.82 | Low | 65.49 | High | 66.09 | Mkt Cap | 8.23B |
| Vol | 1.06M | Avg Vol | 1.49M | EPS | 1.86 | P/E | 35.46 | Forward P/E | 34.47 |
| Beta | 0.42 | Short Ratio | 4.36 | Inst. Own | 117.67% | Dividend | 3.20 | Div Yield | 4.87 |
| Ex Div Date | 09-30 | Earning | 10-20 | 50-d Avg | 71.56 | 200-d Avg | 74.95 | 1yr Est | 82.89 |
ADC News
Two 59-year-olds hold the exact same six income funds at the exact same weights, yet one pays a fede
Agree Realty could be one of the most attractive REITs to own when market turbulence strikes. A clos
A stock-only portfolio paying over $12,000 a month sounds like a retirement dream, but the income sp
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks E
More than half of Americans fear outliving their savings, and the usual advice to "just invest" igno
A $500,000 portfolio of high-yield REITs and BDCs can quietly hand five figures every year straight
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should tak
Some dividends are backed by nothing more than last quarter's earnings, but a handful of companies c
$86.6 Million Private Placement announced, with participation from new and existing investors, exten
Both Realty Income and Agree Realty pay monthly dividends, own net lease properties, and have pulled
Both NNN and Agree Realty cut identical deals with tenants, raised guidance the same summer, and dro
Monthly dividends sound like a paycheck replacement, but the schedule is the easy part. Three REITs
Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the successful closing of AstraZeneca's (LSE
Patent discloses uses beyond ADCs, including autologous or allogeneic adoptive cellular immunotherap
Phase 1/2 APOLLO global clinical trial to evaluate CR-002 in multiple solid tumor types, including n
Three income buckets and eight holdings can close the gap between your current savings and a five-fi
[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced results from Part C of the Phase 1/2 RAINFOLâ
Most retirees lean on Social Security as their primary income, but a dividend portfolio sized correc
Truist Securities analyst Linda Tsai assumes Agree Realty (NYSE:ADC) with a Buy rating and lowers
Simon Property Group and Agree Realty offer 4%+ yields and double-digit total return potential amid
Summit Therapeutics Inc. (Nasdaq: SMMT) today announced a clinical trial collaboration agreement wit
The 10-year Treasury yield just hit a year-long high and dragged every one of these net lease REITs
Montreal, Quebec--(Newsfile Corp. - October 1, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:
Evercore ISI Group analyst James Kammert maintains Agree Realty (NYSE:ADC) with a Outperform and
Stifel analyst Simon Yarmak maintains Agree Realty (NYSE:ADC) with a Buy and lowers the price tar
Mizuho analyst Haendel St. Juste maintains Agree Realty (NYSE:ADC) with a Neutral and lowers the
The Print Agree Realty (NYSE:ADC) and NNN REIT (NYSE:NNN) entered the second half with annualized
Agree Realty (NYSE:ADC) reported quarterly earnings of $1.14 per share which beat the analyst consen
Barclays analyst Richard Hightower maintains Agree Realty (NYSE:ADC) with a Equal-Weight and rais
A July filing shows that Representative Josh Gottheimer reported a sale in Agree Realty (NYSE:ADC),
Barclays analyst Richard Hightower maintains Agree Realty (NYSE:ADC) with a Equal-Weight and lowe
Top Wall Street analysts updated their ratings on top companies. For full list of changes, including
Mizuho analyst Haendel St. Juste maintains Agree Realty (NYSE:ADC) with a Neutral and lowers the
RBC Capital analyst Brad Heffern maintains Agree Realty (NYSE:ADC) with a Outperform and raises t
Baird analyst RJ Milligan maintains Agree Realty (NYSE:ADC) with a Outperform and raises the pric
Agree Realty (NYSE:ADC) reported quarterly earnings of $1.14 per share which beat the analyst consen
Barclays analyst Richard Hightower maintains Agree Realty (NYSE:ADC) with a Equal-Weight and rais
High-yielding stocks are often sought during market turbulence; Benzinga provides latest analyst rat
BMO Capital analyst Eric Borden downgrades Agree Realty (NYSE:ADC) from Outperform to Market Perf
Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that its Board of Direc
Truist Securities analyst Ki Bin Kim maintains Agree Realty (NYSE:ADC) with a Buy and raises the
Evercore ISI Group analyst James Kammert maintains Agree Realty (NYSE:ADC) with a Outperform and
Raymond James analyst RJ Milligan maintains Agree Realty (NYSE:ADC) with a Strong Buy and raises
Barclays analyst Richard Hightower maintains Agree Realty (NYSE:ADC) with a Equal-Weight and rais
Mizuho analyst Haendel St. Juste maintains Agree Realty (NYSE:ADC) with a Neutral and raises the